锥形束CT检测经皮肾镜取石术后残留结石的随机对照试验(CAPTURE)方案
CAPTURE试验是一项研究者发起的单中心随机对照试验,纳入320例有经皮肾镜取石术(PCNL)指征的成人患者。当术者通过透视和肾镜确认无结石后,将患者随机分入术中行锥形束CT(CBCT)扫描的研究组或不行的对照组。主要终点为术后4周低剂量平扫腹部CT评估的无结石状态,次要终点包括所需PCNL次数和结石相关事件数。
要点
- CAPTURE试验旨在评估PCNL术中CBCT扫描能否降低结石相关发病率。
- 主要终点为术后4周低剂量平扫腹部CT评估的无结石状态。
- 计划纳入320例PCNL术后经透视和肾镜确认无结石的成人患者。
核心结论
- 本试验旨在通过比较术中行CBCT与不行CBCT患者的结石相关发病率差异,确定CBCT在PCNL中的附加价值。
研究设计与样本
- 研究者发起的单中心随机对照试验(RCT),纳入有PCNL指征的成人患者320例。
- 术者经透视和肾镜确认无结石后,随机分入术中行CBCT扫描的研究组或不行CBCT扫描的对照组。
- 主要终点为术后4周低剂量平扫腹部CT评估的无结石状态;次要终点包括所需PCNL次数和登记的结石相关事件数。
局限性
- 原文指出,由于随机分组时无法对泌尿科医生设盲,可能产生一些偏倚。
- 原文认为,研究的实用性、标准化条件和预设结局指标的随访方法将带来高水平的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Percutaneous nephrolithotomy (PCNL) is the standard surgical treatment method for large kidney stones. Its aim is to achieve a stone-free status, since any residual fragments (RFs) after PCNL are likely to cause additional morbidity or stone growth. Enhancing intraoperative detectability of RFs could lead to increased stone-free rates and decreased re-intervention rates. Cone beam computed tomography (CBCT) has recently been introduced in urology as a feasible method for intraoperatively imaging RFs. The aim of this trial is to determine the added value of CBCT in percutaneous nephrolithotomy, by measuring differences in stone-related morbidity for patients with procedures in which a CBCT is used versus patients with procedures without the use of CBCT. METHODS: The CAPTURE trial is an investigator-initiated single-center, randomized controlled trial (RCT) in adult patients who have an indication for percutaneous nephrolithotomy. A contemporary percutaneous nephrolithotomy is performed. Once the surgeon is convinced of a stone-free status by means of fluoroscopy and nephroscopy, randomization allocates patients to either the study group in whom an intraoperative CBCT scan is performed or to the control group in whom no intraoperative CBCT scan is performed. The main endpoint is the stone-free status as assessed four weeks postoperatively by low-dose non-contrast abdominal CT, as a standard follow-up procedure. Secondary endpoints include the number of PCNL procedures required and the number of stone-related events (SREs) registered. The total study population will consist of 320 patients that undergo PCNL and are eligible for randomization for an intraoperative CBCT scan. DISCUSSION: We deem a randomized controlled trial to be the most effective and reliable method to assess the efficacy of CBCT in PCNL. Though some bias may occur due to the impossibility of blinding the urologist at randomization, we estimate that the pragmatic nature of the study, standardized circumstances, and follow-up methods with pre-defined outcome measures will result in a high level of evidence. TRIAL REGISTRATION: Netherlands Trial Register (NTR) NL8168 , ABR NL70728.042.19. Registered on 15 October 2019. Prospectively registered.
引用
- Kingma RA, de Jong IJ, Greuter MJW, et al. Cone beam computed tomography for detecting residual stones in percutaneous nephrolithotomy, a randomized controlled trial (CAPTURE) protocol. Trials. 2021. PMID: 34781993. doi:10.1186/s13063-021-05794-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。